Inhibrx

Pharos IBT

This company develops artificial intelligence platforms for discovering and developing treatments for rare and refractory diseases for the pharmaceutical and biotechnology industries.

ADXS

The company develops bioengineered immunotherapies and precision small molecule drugs for patients with rare tumors and aggressive cancers.

Gossamer Bio

This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.

Spyre (SYRE)

Spyre Therapeutics develops antibody therapies and rational combinations for patients with inflammatory bowel disease and other immune-mediated conditions.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.

LogicBio

This company develops gene editing and delivery platforms to provide one-time treatments for patients with serious, early-onset rare genetic diseases.